- Product Details
Keywords
- Lenvatinib Mesilate
- 99.0%
- Frontida
Quick Details
- ProName: Lenvatinib Mesilate
- CasNo: 857890-39-2
- Application: Cancer
- ProductionCapacity: Metric Ton/Day
- Purity: 99.0%
- LimitNum: 0 Metric Ton
Superiority
It is a first-line targeted drug for advanced liver cancer and has been approved in many countries. Its indications include thyroid cancer, advanced renal cell carcinoma and liver cancer.